Predicted protein targets (top 7)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | DRD3 | P35462 | 2/20 | 0.72 |
| ▸ | CNR2 | P34972 | 11/20 | 0.57 |
| ▸ | CNR1 | P21554 | 8/20 | 0.57 |
| ▸ | NR1I2 | O75469 | 1/20 | 0.49 |
| ▸ | ADORA3 | P0DMS8 | 1/20 | 0.49 |
| ▸ | SLC6A3 | Q01959 | 1/20 | 0.49 |
| ▸ | GLRA1 | P23415 | 1/20 | 0.49 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL17388428 | 1.00 | DRD3 (0.72) | DRD3CNR2CNR1NR1I2ADORA3 | |
| SCHEMBL31546114 | 0.99 | DRD3 (0.74) | DRD3CNR2CNR1NR1I2ADORA3 | |
| SCHEMBL31545238 | 0.99 | DRD3 (0.74) | DRD3CNR2CNR1NR1I2ADORA3 | |
| SCHEMBL17388532 | 0.99 | DRD3 (0.74) | DRD3CNR2CNR1NR1I2ADORA3 | |
| SCHEMBL17388329 | 0.99 | DRD3 (0.74) | DRD3CNR2CNR1NR1I2ADORA3 | |
| SCHEMBL31545000 | 0.97 | DRD3 (0.71) | DRD3CNR2CNR1NR1I2ADORA3 | |
| SCHEMBL17388682 | 0.97 | DRD3 (0.71) | DRD3CNR2CNR1NR1I2ADORA3 | |
| SCHEMBL17388506 | 0.94 | DRD3 (0.68) | DRD3CNR2CNR1NR1I2ADORA3 | |
| SCHEMBL31545575 | 0.94 | DRD3 (0.68) | DRD3CNR2CNR1NR1I2ADORA3 | |
| SCHEMBL17388530 | 0.90 | CNR2 (0.71) | DRD3CNR2CNR1NR1I2ADORA3 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20250090554-A1 | A METHOD OF TREATING DEPRESSION BY IMMUNE MODULATION | MYND LIFE SCIENCES INC (CA) | 2025-03-20 | — | — | US | disclosed |